Lista de obras - Rita Sattler - Dominio Público Uruguay

A comprehensive library of familial human amyotrophic lateral sclerosis induced pluripotent stem cells

artículo científico publicado en 2015

ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD

scientific article published on 03 April 2019

Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?

artículo científico publicado en 2014

Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis

artículo científico publicado en 2017

Biomarker development for C9orf72 repeat expansion in ALS.

artículo científico

C9orf72 nucleotide repeat structures initiate molecular cascades of disease.

artículo científico publicado en 2014

Correction to: ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD

artículo científico publicado en 2019

Generation of GFAP::GFP astrocyte reporter lines from human adult fibroblast-derived iPS cells using zinc-finger nuclease technology

artículo científico publicado en 2015

Generation of two induced pluripotent stem cell (iPSC) lines from an ALS patient with simultaneous mutations in KIF5A and MATR3 genes

artículo científico publicado en 2020

Genetic and functional studies of a missense variant in a glutamate transporter, SLC1A3, in Tourette syndrome

scientific article published on 01 April 2011

GluR1 controls dendrite growth through its binding partner, SAP97.

artículo científico publicado en 2008

Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS

artículo científico publicado en 2019

Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS: Supplemental Materials and Figures

Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression ⬇️

artículo científico publicado el 27 de octubre de 2010

High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells

artículo científico publicado en 2015

Human nasal olfactory epithelium as a dynamic marker for CNS therapy development

artículo científico publicado en 2011

Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes

artículo científico publicado en 2013

Increased expression of glutamate transporter GLT-1 in peritumoral tissue associated with prolonged survival and decreases in tumor growth in a rat model of experimental malignant glioma ⬇️

artículo científico publicado el 2 de agosto de 2013

Inhibition of xc- transporter-mediated cystine uptake by sulfasalazine analogs ⬇️

artículo científico publicado el 12 de agosto de 2011

Molecularly defined cortical astroglia subpopulation modulates neurons via secretion of Norrin

scientific article published on 01 April 2019

Mutant disrupted-in-schizophrenia 1 in astrocytes: focus on glutamate metabolism

artículo científico publicado en 2014

Persistent hippocampal CA1 LTP in mice lacking the C-terminal PDZ ligand of GluR1.

artículo científico publicado en 2005

Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS.

artículo científico publicado en 2017

RNA Editing Deficiency in Neurodegeneration

artículo científico publicado en 2018

RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention

artículo científico publicado en 2013

Reactivation of nonsense-mediated mRNA decay protects against C9orf72 dipeptide-repeat neurotoxicity ⬇️

Representing Diversity in the Dish: Using Patient-Derived in Vitro Models to Recreate the Heterogeneity of Neurological Disease

artículo científico publicado en 2018

Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.

artículo científico publicado en 2018

TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.

artículo científico publicado en 2018

Targeting an old mechanism in a new disease-protection of glutamatergic dysfunction in depression

artículo científico publicado en 2007

The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.

artículo científico publicado en 2015

The Hitchhiker's Guide to Nucleocytoplasmic Trafficking in Neurodegeneration

scientific article published on 21 February 2020

The M1311V variant of ATP7A is associated with impaired trafficking and copper homeostasis in models of motor neuron disease

artículo científico publicado en 2020

The transcription factor Pax6 contributes to the induction of GLT-1 expression in astrocytes through an interaction with a distal enhancer element

artículo científico publicado en 2015

Lista de obras de Rita Sattler

A comprehensive library of familial human amyotrophic lateral sclerosis induced pluripotent stem cells

ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD

Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?

Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis

Biomarker development for C9orf72 repeat expansion in ALS.

C9orf72 nucleotide repeat structures initiate molecular cascades of disease.

Correction to: ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD

Generation of GFAP::GFP astrocyte reporter lines from human adult fibroblast-derived iPS cells using zinc-finger nuclease technology

Generation of two induced pluripotent stem cell (iPSC) lines from an ALS patient with simultaneous mutations in KIF5A and MATR3 genes

Genetic and functional studies of a missense variant in a glutamate transporter, SLC1A3, in Tourette syndrome

GluR1 controls dendrite growth through its binding partner, SAP97.

Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS

Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS: Supplemental Materials and Figures

Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression ⬇️

High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells

Human nasal olfactory epithelium as a dynamic marker for CNS therapy development

Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes

Increased expression of glutamate transporter GLT-1 in peritumoral tissue associated with prolonged survival and decreases in tumor growth in a rat model of experimental malignant glioma ⬇️

Inhibition of xc- transporter-mediated cystine uptake by sulfasalazine analogs ⬇️

Molecularly defined cortical astroglia subpopulation modulates neurons via secretion of Norrin

Mutant disrupted-in-schizophrenia 1 in astrocytes: focus on glutamate metabolism

Persistent hippocampal CA1 LTP in mice lacking the C-terminal PDZ ligand of GluR1.

Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS.

RNA Editing Deficiency in Neurodegeneration

RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention

Reactivation of nonsense-mediated mRNA decay protects against C9orf72 dipeptide-repeat neurotoxicity ⬇️

Representing Diversity in the Dish: Using Patient-Derived in Vitro Models to Recreate the Heterogeneity of Neurological Disease

Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.

TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.

Targeting an old mechanism in a new disease-protection of glutamatergic dysfunction in depression

The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.

The Hitchhiker's Guide to Nucleocytoplasmic Trafficking in Neurodegeneration

The M1311V variant of ATP7A is associated with impaired trafficking and copper homeostasis in models of motor neuron disease

The transcription factor Pax6 contributes to the induction of GLT-1 expression in astrocytes through an interaction with a distal enhancer element